Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Differential effects of anthracycline drugs on rat heart and liver microsomal reduced nicotinamide adenine dinucleotide phosphate-dependent lipid peroxidation.

× No keyword cloud information.

17 in total

1. The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patients.

Authors: M A Graham; D R Newell; B J Foster; A H Calvert
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

2. Interaction of anthracycline antibiotics with human neutrophils: superoxide production, free radical formation and intracellular penetration.

Authors: M L Schinetti; D Rossini; A Bertelli
Journal: J Cancer Res Clin Oncol Date: 1987 Impact factor: 4.553

3. Doxorubicin Redox Biology: Redox Cycling, Topoisomerase Inhibition, and Oxidative Stress.

Authors: Hong Zhu; Soumyadeep Sarkar; Laura Scott; Igor Danelisen; Michael A Trush; Zhenquan Jia; Y Robert Li
Journal: React Oxyg Species (Apex) Date: 2016

Review 4. Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors: D Faulds; J A Balfour; P Chrisp; H D Langtry
Journal: Drugs Date: 1991-03 Impact factor: 9.546

5. Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.

Authors: G Minotti; A F Cavaliere; A Mordente; M Rossi; R Schiavello; R Zamparelli; G Possati
Journal: J Clin Invest Date: 1995-04 Impact factor: 14.808

6. Development of mitoxantrone.

Authors: R J White; F E Durr
Journal: Invest New Drugs Date: 1985 Impact factor: 3.850

7. Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity.

Authors: J A Jackson; J P Reeves; K H Muntz; D Kruk; R A Prough; J T Willerson; L M Buja
Journal: Am J Pathol Date: 1984-10 Impact factor: 4.307

8. A new combination of two intercalating agents (mitoxantrone + daunomycin) in adult refractory acute leukemia: the DON protocol.

Authors: J P Laporte; N C Gorin; M P Lemonnier; F Isnard; A Najman
Journal: Cancer Chemother Pharmacol Date: 1988 Impact factor: 3.333

Review 9. Glutathione-related enzymes, glutathione and multidrug resistance.

Authors: J A Moscow; K H Dixon
Journal: Cytotechnology Date: 1993 Impact factor: 2.058

10. Mitoxantrone: propensity for free radical formation and lipid peroxidation--implications for cardiotoxicity.

Authors: R F Novak; E D Kharasch
Journal: Invest New Drugs Date: 1985 Impact factor: 3.850